As of 2026-06-10, the Relative Valuation of Mayinglong Pharmaceutical Group Co Ltd (600993.SS) is 32.65 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 24.00 CNY, the upside of Mayinglong Pharmaceutical Group Co Ltd based on Relative Valuation is 36.0%.
The range of the Relative Valuation is 25.77 - 55.49 CNY.
| Range | Selected | |
| Trailing P/E multiples | 22.3x - 40.5x | 25.2x |
| Forward P/E multiples | 15.7x - 24.4x | 18.8x |
| Fair Price | 25.77 - 55.49 | 32.65 |
| Upside | 7.4% - 131.2% | 36.0% |
| Date | P/E |
| 2026-06-02 | 17.74 |
| 2026-06-01 | 17.72 |
| 2026-05-29 | 17.65 |
| 2026-05-28 | 16.99 |
| 2026-05-27 | 17.38 |
| 2026-05-26 | 17.39 |
| 2026-05-25 | 17.44 |
| 2026-05-22 | 17.59 |
| 2026-05-21 | 17.69 |
| 2026-05-20 | 17.94 |
| 2026-05-19 | 18.19 |
| 2026-05-18 | 18.13 |
| 2026-05-15 | 18.62 |
| 2026-05-14 | 18.71 |
| 2026-05-13 | 19.02 |
| 2026-05-12 | 19.13 |
| 2026-05-11 | 19.03 |
| 2026-05-08 | 18.40 |
| 2026-05-07 | 18.44 |
| 2026-05-06 | 18.82 |
| 2026-04-30 | 18.99 |
| 2026-04-29 | 19.05 |
| 2026-04-28 | 18.89 |
| 2026-04-27 | 18.94 |
| 2026-04-24 | 18.35 |
| 2026-04-23 | 18.30 |
| 2026-04-22 | 18.18 |
| 2026-04-21 | 18.09 |
| 2026-04-20 | 18.27 |
| 2026-04-17 | 18.06 |
| 2026-04-16 | 18.30 |
| 2026-04-15 | 18.49 |
| 2026-04-14 | 18.36 |
| 2026-04-13 | 18.35 |
| 2026-04-10 | 18.57 |
| 2026-04-09 | 18.54 |
| 2026-04-08 | 18.77 |
| 2026-04-07 | 18.50 |
| 2026-04-03 | 18.45 |
| 2026-04-02 | 18.75 |
| 2026-04-01 | 18.65 |
| 2026-03-31 | 18.35 |
| 2026-03-30 | 18.42 |
| 2026-03-27 | 18.56 |
| 2026-03-26 | 18.35 |
| 2026-03-25 | 18.41 |
| 2026-03-24 | 18.19 |
| 2026-03-23 | 18.15 |
| 2026-03-20 | 18.69 |
| 2026-03-19 | 18.73 |